DaVitaBSP:DVAI34 +2.39%75 Dividend Yield % is 0.00% as of Jul. 01, 2026. GuruFocus rates BSP:DVAI34 with a GF Score™ of 75/100 and a GF Value™ of R$900.89 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 281 Healthcare Providers & Services companies, DaVita ranks worse than 355871.53% on this metric.
As of today (2026-07-01), the Trailing Annual Dividend Yield of DaVita is 0.00%.
The historical rank and industry rank for DaVita's Dividend Yield % or its related term are showing as below:
BSP:DVAI34's Dividend Yield % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 2.37 * Ranked among companies with meaningful Dividend Yield % only.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
DaVita (BSP:DVAI34) Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
The historical data trend for DaVita's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BSP:DVAI34 vs THC, EHC, ENSG: Dividend Yield % Comparison
For the Medical Care Facilities subindustry, DaVita's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DaVita Dividend Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, DaVita's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where DaVita's Dividend Yield % falls into.
DaVita (BSP:DVAI34) has a Dividend Yield % of 0.00% as of Jul. 01, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on DaVita and its competitors. According to the industry distribution chart, DaVita ranks #999999 out of 281 companies in the Healthcare Providers & Services industry.
Is DaVita's Dividend Yield % too high?
DaVita's current Dividend Yield % is 0.00%. Based on the distribution chart, DaVita ranks #999999 out of 281 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, DaVita has a GF Score™ of 75/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does DaVita's Dividend Yield % compare to THC and EHC?
According to the Healthcare Providers & Services industry distribution chart, DaVita ranks #999999 out of 281 companies for Dividend Yield %. This places DaVita in the lower half of its industry. The industry median Dividend Yield % is 2.37. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Healthcare Providers & Services company?
The median Dividend Yield % among Healthcare Providers & Services companies is 2.37, based on 281 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on DaVita and its competitors. For the Healthcare Providers & Services industry, the median Dividend Yield % is 2.37 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DaVita's current Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DaVita stock overvalued right now?
Based on GuruFocus' analysis, DaVita (BSP:DVAI34) is currently considered Modestly Overvalued. The stock's GF Value™ is R$900.89, compared to a current price of R$1,151.37 — trading 27.8% above its estimated fair value. The current Dividend Yield % is 0.00%. DaVita's overall GF Score™ is 75/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For DaVita (BSP:DVAI34), the current Dividend Yield % is 0.00% as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DaVita (BSP:DVAI34) Overvalued in 2026?
Based on GuruFocus' analysis, DaVita stock appears to be overvalued.
The current stock price of R$1,151.37 is trading 27.8% above its estimated GF Value™ of R$900.89.
GuruFocus considers DaVita to be Modestly Overvalued.
Key valuation signals for BSP:DVAI34:
Dividend Yield %: 0.00%
GF Value™: R$900.89 vs. price of R$1,151.37 (27.8% above fair value)
No single metric tells the full story. See the BSP:DVAI34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.
75GF Score
Get the complete analysis for BSP:DVAI34
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:DVAI34 has been successfully added to your 
